Epigentek Home

Product Categories
Related Products

EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit (H3K9)


Base Product #: P-3003              Availability: Usually Ships In 1-2 Days
Share:
Displaying 1 to 2 (of 2 products) Result Pages:  1 
 Catalog No.+   Product Name   Select Qty.   Price 
 P-3003-1  EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit (H3K9) (48 assays)   $299.00 
 P-3003-2  EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit (H3K9) (96 assays)   $499.00 
Product Overview

The EpiQuik™ Histone Methyltransferase Activity/Inhibition Kit (H3-K9) is a convenient set of tools that allows the experimenter to measure the activity or inhibition of individual histone methyltransferase that specifically target histone H3 at lysine 9 (H3-K9). The kit is ready-to-use and provides all the essential components needed to carry out a successful HMT activity/inhibition experiment without the need for radioactivity or any special equipment.

WHY CHOOSE THE EPIQUIK™ HISTONE METHYLTRANSFERASE ACTIVITY/INHIBITION ASSAY KIT (H3-K9)?

  • Very rapid procedure, which can be completed within 3 hours.
  • Safe and innovative colorimetric assay without radioactivity, extraction, and chromatography.
  • Specific measurement of activity/inhibition of H3-K9 histone methyltransferases.
  • Strip microplate format makes the assay flexible: manual or high throughput analysis.
  • Extremely simple, reliable, and consistent assay conditions.
Product Details

The EpiQuik™ Histone Methyltransferase Activity/Inhibition Assay Kit (H3-K9) is designed for measuring HMTs that specifically target histone H3 at lysine 9. In an assay with this kit, the histone substrate is stably captured on the strip wells. HMT enzymes transfer a methyl group to histone H3 substrate from Adomet to methylate the substrate at lysine 9. The methylated histone H3-K9 can be recognized with a high-affinity antibody. The ratio or amount of methylated H3-K9, which is directly proportional to enzyme activity, can be quantified through a HRP conjugated secondary antibody-color development system. The HMT activity is then calculated based on the amount of methylated H3-K9 converted by the HMTs.

SCHEMATIC PROCEDURE:  


Nuclear extracts were prepared from MCF-7 cells using the EpiQuik Nuclear Extraction Kit and H3-K9 specific histone methyltrasferase activity (G9a) was measured.
Product Components

HK1 (10X Wash Buffer)
HK2 (Histone Assay Buffer)
HK3 (Adomet)*
HK4 (Biotinylated Substrate, 25 µg/ml)*
HK5 (HMT Standard, 10 µg/ml)*
HK6 (Capture Antibody, 100 µg/ml)*
HK7 (Detection Antibody, 200 µg/ml)*
HK8 (Developing Solution)
HK9 (Stop Solution)
Control Enzyme (150 µg/ml)*
8-Well Assay Strips (with frame)
User Guide

* For maximum recovery of the products, centrifuge the original vial after thawing prior to opening the cap.

Frequently Asked Q's

1. Can the nuclear extract be increased for the reaction?
Yes, but not more than 6 µl.

3. If the protein concentration extracted is low (0.5 µg/µl), how much extraction can be added in the reaction?
Increase the concentration of nuclear protein during protein extraction (using more sample amount or reduce volume), and then add more sample solution to the reaction (up to 6 µl).

User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

[Material Safety Data Sheet]
Product Citations

Chestnut, BA. et. al. (November 2011). Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation. J. Neurosci. 31(46):16619-36. PubMed Abstract

Feedback Form
Epigentek is an epigenetics company that specializes in epigenetic kits, antibodies, reagents, and services for epigenetic research in DNA methylation, histone modification, and chromatin studies.

Copyright © 2012 Epigentek Group Inc. All rights reserved.
Epigentek, the Epigentek logo, and the "Complete Solutions For Epigenetics" slogan are trademarks of Epigentek Group Inc.